Black Rock Inc. Amneal Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 11,282,430 shares of AMRX stock, worth $102 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,282,430
Previous 9,164,172
23.11%
Holding current value
$102 Million
Previous $55.5 Million
29.01%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMRX
# of Institutions
247Shares Held
144MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$158 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$106 Million2.18% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$50.7 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.3MShares$47.8 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.37B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...